Amgen (AMGN) EBT Margin (2009 - 2026)

Amgen's EBT Margin history runs 18 years deep, the most recent figure standing at 24.18% for Q1 2026.

• In Q1 2026, EBT Margin fell 3.0% year-over-year to 24.18%; the TTM figure through Mar 2026 stood at 24.41% (up 493.0% YoY), while the FY2025 annual figure was 24.42%, up 1063.0% from the prior year.
• EBT Margin was 24.18% for Q1 2026 at Amgen, up from 15.35% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 380.83% in Q4 2022 to a low of 0.91% in Q1 2024.
• Historically, EBT Margin has averaged 44.73% across 5 years, with a median of 24.18% in 2026.
• The sharpest annual moves came in 2022 and 2023: EBT Margin jumped 34970 bps in 2022, then sank 37043 bps in 2023.
• A 5-year view of EBT Margin shows it stood at 380.83% in 2022, then plunged by 97 bps to 10.4% in 2023, then declined by 17 bps to 8.61% in 2024, then soared by 78 bps to 15.35% in 2025, then jumped by 58 bps to 24.18% in 2026.
• The last three EBT Margin figures came in at 24.18% (Q1 2026), 15.35% (Q4 2025), and 41.03% (Q3 2025), per Business Quant data.